ClinicalTrials.govpublic full text
The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)
to define an easy and feasible panel which may be routinely applied to select patients for immunotherapy avoiding more complex and expensive methods
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 417530
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.